Axa
TNDM icon

Axa’s Tandem Diabetes Care TNDM Stock Holding History

Axa’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,156
Closed -$1.17M – 1133
2023
Q3 		$1.17M Sell
56,156
-185,584
-77% -$5.1M ﹤0.01% 813
2023
Q2 		$5.93M Hold
241,740
– – 0.02% 515
2023
Q1 		$9.82M Sell
241,740
-337,519
-58% -$14M 0.03% 417
2022
Q4 		$26M Buy
579,259
+92,349
+19% +$4.18M 0.09% 258
2022
Q3 		$23.3M Buy
486,910
+66,958
+16% +$3.67M 0.09% 255
2022
Q2 		$24.9M Buy
419,952
+104,602
+33% +$8.59M 0.09% 256
2022
Q1 		$36.7M Buy
315,350
+3,541
+1% +$413K 0.1% 225
2021
Q4 		$46.9M Buy
311,809
+24,822
+9% +$3.35M 0.12% 199
2021
Q3 		$34.3M Buy
286,987
+63,600
+28% +$7.01M 0.1% 241
2021
Q2 		$21.8M Buy
223,387
+38,815
+21% +$3.46M 0.06% 325
2021
Q1 		$16.3M Buy
+184,572
New +$17.2M 0.05% 396
2020
Q3 		– Sell
-8,400
Closed -$831K – 1354
2020
Q2 		$831K Sell
8,400
-106,604
-93% -$8.51M ﹤0.01% 983
2020
Q1 		$7.4M Sell
115,004
-9,350
-8% -$655K 0.04% 432
2019
Q4 		$7.41M Buy
124,354
+94,516
+317% +$5.83M 0.03% 515
2019
Q3 		$1.76M Buy
+29,838
New +$1.9M 0.01% 889

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axa's TNDM Position: Q4 2023 in Review

Axa sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 56,156 shares — an estimated $1.17M sold.

Axa first reported a position in TNDM in Q3 2019 and held it in 15 quarters. The position peaked at $46.9M in Q4 2021. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Axa reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Axa sold 56,156 Tandem Diabetes Care shares in Q4 2023, an estimated $1.17M.
  • Axa first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 15 quarters.
  • Axa's Tandem Diabetes Care position peaked at $46.9M in Q4 2021.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Axa's 13F filing for Q4 2023, filed 14 Feb 2024.